<DOC>
	<DOCNO>NCT00979056</DOCNO>
	<brief_summary>The aim study investigate efficacy prophylactic treatment rifaximin prevent traveller diarrhoea .</brief_summary>
	<brief_title>Prophylactic Treatment Travellers ' Diarrhoea With Rifaximin</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Adults ≥ 18 &lt; 65 year Good general condition ( accord history clinical examination ) Written inform consent No pregnancy No breast feed Efficacious contraception ( e.g . oral , doublebarrier ) study 4 week termination study No participation clinical trial 4 week , participation , 4 week participation study Planned travel period 6 28 day Planned travel South Southeast Asia Planned time arrival South Southeast Asia ≤ 24 hour Pregnancy Breast feeding Age &lt; 18 ≥ 65 year No write inform consent Chronic gastrointestinal disease and/ immune insufficiency Low general condition ( accord history clinical examination ) Regular medication gastrointestinal sideeffects and/or immunosuppressive medication Participation clinical trial 4 week , 4 week termination study No efficacious contraception Planned travel period &lt; 6 &gt; 28 day Planned travel outside South Southeast Asia Vaccination cholera use DUKORAL within 12 month prior inclusion Planned time arrival South Southeast Asia &gt; 24 hour Known hypersensitivity rifaximin rifamycinderivatives general Known lactose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Traveller 's diarrhoea</keyword>
	<keyword>Prevention</keyword>
</DOC>